These cells release a spectrum of immunosuppressive cytokines, including transforming growth factor-beta (TGF-β) and interleukin-10 (IL-10), which further diminish the activity of effector T cells and promote tumor tolerance (Fig. 1) [22]. The gene discussed is IL10; the disease is neoplasm.